3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Carcinoma
6
Lung Neoplasms
5
Nasopharyngeal Carcinoma
4
Mouth Neoplasms
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Mesothelioma, Malignant
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Adenocarcinoma of Lung
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Mesothelioma
1
Medulloblastoma
1
Locally Advanced Cervical Adenocarcinoma
1
Liver Neoplasms
1
Interventions
pembrolizumab
23
Carboplatin
23
Paclitaxel
17
Specimen Handling
15
Magnetic Resonance Spectroscopy
11
Cyclophosphamide
10
Biopsy
10
Taxes
7
Capecitabine
7
Nivolumab
6
130-nm albumin-bound paclitaxel
6
sacituzumab govitecan
5
Gemcitabine
5
Doxorubicin
5
Albumin-Bound Paclitaxel
5
Fulvestrant
4
olaparib
3
fludarabine
3
eribulin
3
durvalumab
3
atezolizumab
3
Letrozole
3
Epirubicin
3
Bevacizumab
3
veliparib
2
poly ICLC
2
pertuzumab
2
aldesleukin
2
abemaciclib
2
Trastuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
1,2-diaminocyclohexaneplatinum II citrate
×
30 days
×
Clear all
No trials found.